News
10-10-2010, 09:50 PM
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
More... (http://www.news-medical.net/news/20101011/Anti-HER2-antibody-drug-conjugate-effective-for-first-line-therapy-in-advanced-breast-cancer-Research.aspx)
More... (http://www.news-medical.net/news/20101011/Anti-HER2-antibody-drug-conjugate-effective-for-first-line-therapy-in-advanced-breast-cancer-Research.aspx)